Shopping Cart   Contact Us   Home

To view the report in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will launch the file so that you can see the document on your monitor and then print it. Download Adobe Acrobat.

Download the ReportPremium Resource

 
Find a wealth of reports, white papers and other behavioral health and social service resources in the 
OPEN MINDS
Industry Resources Library.

 

June 2, 2004

ShareThe People of the State of New York, by Eliot Spitzer, Attorney General of the State of New York, Complaint made against GlaxoSmithKline, PLC

GIaxoSmithKline, pIc and SmithKline Beecham Corporation (doing business as GlaxoSmithKline and together referred to as "GSK") are collectively a pharmaceutical manufacturer with net income (adjusted earnings) in 2002 of over $6.9 billion. GSK has engaged in repeated and persistent fraud by misrepresenting, concealing and otherwise failing to disclose to physicians information in its control concerning the safety and effectiveness of its antidepressant medication paroxetine HCL ("paroxetine") in treating children and adolescents with Major Depressive Disorder ("MDD"). GSK sells paroxetine in the United States under the names Paxi]@ and Paxi] CRTM. Unti] 2003, GSK had market exclusivity for paroxetine in the US.

Premium Membership Required

 

 


Shopping Cart | Contact Us | Home

OPEN MINDS